These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8723299)

  • 21. Metabolic correlates of levodopa response in Parkinson's disease.
    Feigin A; Fukuda M; Dhawan V; Przedborski S; Jackson-Lewis V; Mentis MJ; Moeller JR; Eidelberg D
    Neurology; 2001 Dec; 57(11):2083-8. PubMed ID: 11739830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pharmacokinetic effect of haloperidol on DA receptors].
    Giorgobiani IB; Kitiashvili SA
    Georgian Med News; 2005 Mar; (120):68-70. PubMed ID: 15855705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional cerebral glucose metabolism in major depressive disorder.
    Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
    Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
    Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
    Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in local cerebral glucose utilization and dopamine metabolism in the rat brain following acute administration of haloperidol.
    Kurachi M; Yasui S; Shibata R; Murata M; Hagino H; Tanii Y; Kurata K
    Jpn J Psychiatry Neurol; 1993 Dec; 47(4):921-8. PubMed ID: 8201804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.
    Buchsbaum MS; Potkin SG; Siegel BV; Lohr J; Katz M; Gottschalk LA; Gulasekaram B; Marshall JF; Lottenberg S; Teng CY
    Arch Gen Psychiatry; 1992 Dec; 49(12):966-74. PubMed ID: 1449383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of effects of haloperidol on energy metabolism in the rat brain.
    McCulloch J; Savaki HE; Sokoloff L
    Brain Res; 1982 Jul; 243(1):81-90. PubMed ID: 7116160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
    Knable MB; Heinz A; Raedler T; Weinberger DR
    Psychiatry Res; 1997 Sep; 75(2):91-101. PubMed ID: 9351491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML
    Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Ding YS; Sedler M; Logan J; Franceschi D; Gatley J; Hitzemann R; Gifford A; Wong C; Pappas N
    Am J Psychiatry; 2001 Dec; 158(12):2015-21. PubMed ID: 11729018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of ethanol on regional brain glucose metabolism and transport.
    Volkow ND; Hitzemann R; Wolf AP; Logan J; Fowler JS; Christman D; Dewey SL; Schlyer D; Burr G; Vitkun S
    Psychiatry Res; 1990 Apr; 35(1):39-48. PubMed ID: 2164230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
    Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K
    Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging CNS receptors: the dopaminergic system.
    Wagner HN
    Hosp Pract (Off Ed); 1984 Jun; 19(6):187-91, 195-8, 202. PubMed ID: 6144688
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
    Jaen JC; Caprathe BW; Pugsley TA; Wise LD; Akunne H
    J Med Chem; 1993 Nov; 36(24):3929-36. PubMed ID: 7902870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
    Ben-Shachar D; Youdim MB
    J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of neuroimaging techniques to drug development.
    Tamminga CA; Conley RR
    J Clin Psychiatry; 1997; 58 Suppl 10():3-6. PubMed ID: 9265909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system.
    Cascella NG; Tarazi FI; Shirakawa O; Tamminga CA
    Psychopharmacology (Berl); 1994 Mar; 114(2):275-80. PubMed ID: 7838920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.